|
|
|
| |
|
![]()
|
Pittsburgh, Pa. Wednesday, Jan. 18, 2006 |
Pitt develops wireless version of nerve stimulatorWednesday, January 18, 2006 By Joe Fahy, Pittsburgh Post-GazetteWith help from local high school science teachers, University of Pittsburgh researchers have developed a wireless device that they hope will be safer and less invasive than an existing vagus nerve stimulator. The new device, a radio-frequency-powered neural stimulator, would allow patients to wear a two-inch device containing the stimulator's battery outside the body, clipped under a shirt collar. Like the vagus nerve stimulator developed by Cyberonics Inc., the new device would require an incision in the neck to implant electrodes around the vagus nerve. Unlike the Cyberonics stimulator, the new device would not require a second incision in the chest to implant a pulse generator containing the battery, or tunneling under the skin to thread a wire from the generator to electrodes placed on the vagus nerve. Its use thus could reduce the risk of infection or other surgical complications and would eliminate the need for surgery to replace the battery. Some companies have shown interest in licensing the technology, said Marlin Mickle, professor of electrical and computer engineering at Pitt. It would be up to the company to further develop it and seek Food and Drug Administration approval. The wireless stimulator was adapted from an earlier device developed by Dr. Mickle that uses radio-frequency technology for deep-brain stimulation of patients with Parkinson's disease. Michael Lovell, an associate professor of industrial and mechanical engineering, graduate student Steven Hackworth and Dr. Robert Sclabassi, professor of neurological surgery, also were involved. Last summer, four science teachers from Allderdice, Peabody, Perry and Westinghouse high schools -- Theodora Bennett, Robert Cuda, Kathy Hoelzle and Eric Laurenson -- began working at Pitt under a program funded by the National Science Foundation, helping to convert the device for use in treating seizures. During that process, the FDA approved the Cyberonics device for treatment of depression, and Pitt researchers believe their device also could be used for that purpose.
|
http://www.post-gazette.com/pg/06018/639501.stm
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| New treatment for depression refined |
| Posted 01/30/2006 |
| Knowing that which I do today and
being a support person and health care advocate to my spouse who was
one of the earliest VNS Therapy study patients for depression I would
really question whether this adaptation represents a major improvement
in the therapy. I personally would not consider this approach as
convenient for the patient. Once implanted the current procedure is
essentially activate the prosthesis and forget about it while it
administers its therapy 24/7/365. This adaptation appears to me to
represent a more inconvenient lifestyle for patient in having to wear
some kind of collar almost constantly around one's neck. This would
then mean removal for periods of time for purposes of cleanliness,
possible damage from handling and a question of size. While at first it may seem advancement to those unfamiliar with the prosthesis I do not necessarily see it as such and I am curious why the group didn't think of a similar improvement to cardiac pacemakers with so many more devices in use? I would also point out that the most difficult aspect of the surgery to implant the pulse generator and the lead is the attachment of the lead to the vagus nerve which still remains a surgery in either case. The implanting of the pulse generator in the chest is basically simple and straightforward to which my spouse has had two very uneventful surgeries in 6 years lasting less than one hour each time. In most instances the surgery is performed on an outpatient basis. The media and PR seem to do a good job but I would strongly advocate for the education of the patient and his/her support persons before making any informed and un-coerced medical decisions in collaboration with one's trusted, knowledgeable and licensed health care practitioner(s). There is also a patient advocacy website and message forum sharing and discussing information specifically related to the VNS Therapy option for TRD (Treatment Resistant Depression). The readers might be interested in following up on this subject by investigating "VNSdepression.com" The link to the site is: http://www.vnsdepression.com I extend my best wishes to all those challenged by this horrific illness in then venture to achieve wellness. Warmly, Herb . Herbert Stein information@vnsdepression.com support person, health care advocate and activist Florida |